Variant report

Variant	nsv897139
Chromosome Location	chr11:25801048-25861113
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:25845519..25848193-chr11:25860791..25863329,2	MCF-7	breast:
2	chr11:25813617..25816295-chr11:25817467..25820329,2	K562	blood:
3	chr11:25813617..25816295-chr11:25817467..25820329,2	K562	blood:
4	chr11:25845519..25848193-chr11:25860791..25863329,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ANO3-3	chr11:25803176-25803213	NONHSAT018451
2	lnc-ANO3-3	chr11:25803176-25803305	ENSG00000254456
3	lnc-ANO3-3	chr11:25802028-25802169	ENSG00000254456
4	lnc-ANO3-3	chr11:25802028-25802169	ENSG00000254456
5	lnc-ANO3-3	chr11:25803176-25803213	ENSG00000254456
6	lnc-ANO3-3	chr11:25802028-25802169	NONHSAT018451

No data

Extended variants
information (count: 158 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:158 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs539368073	chr11:25802018-25802019	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs66644014	chr11:25802039-25802040	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
3	rs546782451	chr11:25802073-25802074	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
4	rs4923303	chr11:25802075-25802076	Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs573304090	chr11:25802081-25802082	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
6	rs532425391	chr11:25802095-25802096	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
7	rs4923304	chr11:25802096-25802097	Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs555942963	chr11:25802105-25802106	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
9	rs574053581	chr11:25802107-25802108	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
10	rs569199815	chr11:25802131-25802132	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs183944670	chr11:25802134-25802135	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
12	rs188286655	chr11:25802143-25802144	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
13	rs192611190	chr11:25802154-25802155	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs556668748	chr11:25802164-25802165	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
15	rs545320589	chr11:25802166-25802167	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
16	rs563721765	chr11:25802206-25802207	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs12804811	chr11:25802210-25802211	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs4923305	chr11:25802227-25802228	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs35469275	chr11:25802238-25802239	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs4922741	chr11:25802244-25802245	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs531557339	chr11:25802256-25802257	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs59692593	chr11:25802267-25802268	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs35387720	chr11:25802286-25802287	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs528178982	chr11:25802440-25802441	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs533435691	chr11:25802453-25802454	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs573581657	chr11:25802461-25802462	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs539700070	chr11:25802479-25802480	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs78339067	chr11:25802482-25802483	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs546760018	chr11:25802492-25802493	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs76069944	chr11:25802518-25802519	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs184862887	chr11:25802566-25802567	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs555807884	chr11:25802596-25802597	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs544688487	chr11:25802616-25802617	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs371912780	chr11:25802678-25802679	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs537973172	chr11:25802728-25802729	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs556693246	chr11:25802740-25802741	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs578134250	chr11:25802741-25802742	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs545289488	chr11:25802801-25802802	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs141566734	chr11:25802821-25802822	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs74778925	chr11:25802856-25802857	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs539805110	chr11:25802981-25802982	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs190293057	chr11:25803015-25803016	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs34550098	chr11:25803123-25803124	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs398045061	chr11:25803127-25803128	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs528955007	chr11:25803130-25803131	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs544004058	chr11:25803140-25803141	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs562688849	chr11:25803150-25803151	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs575147023	chr11:25803184-25803185	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
49	rs61741631	chr11:25803296-25803297	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
50	rs551603686	chr11:25803328-25803329	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Multiple myeloma	16461302	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Renal cell carcinoma	18194544	CNVD
Myelofibrosis	22110671	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Autism	22102821	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:6 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:25802000-25803800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr11:25802400-25802600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr11:25815800-25816800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr11:25818400-25818800	Enhancers	Adipose Nuclei	Adipose
5	chr11:25827200-25827800	Enhancers	Fetal Heart	heart
6	chr11:25860600-25861000	Enhancers	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links